Qinan Yin
-
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 5
-
- Cancer Immunotherapy and Biomarkers 8
-
- Blood groups and transfusion 7
-
- RNA modifications and cancer 5
- Circular RNAs in diseases 5
-
- Erythrocyte Function and Pathophysiology 7
-
- Ferroptosis and cancer prognosis 5
- Cited by
- Cancer ResearchOncologyImmunology
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Qinan Yin
42 papers receiving 584 citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Cancer Research 138
- Oncology 216
- Immunology 96
- Hematology 41
- Molecular Biology 242
Countries citing papers authored by Qinan Yin
This map shows the geographic impact of Qinan Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinan Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinan Yin more than expected).
Fields of papers citing papers by Qinan Yin
This network shows the impact of papers produced by Qinan Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinan Yin. The network helps show where Qinan Yin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qinan Yin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 8 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 12 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 10 | |
| 10 | 2024 | 0 | |
| 11 | 2024 | 2 | |
| 12 | 2023 | 14 | |
| 13 | 2023 | 1 | |
| 14 | Immune-related adverse events of immune checkpoint inhibitors: a reviewbreakdown → | 2023 | 189 |
| 15 | 2022 | 27 | |
| 16 | 2021 | 21 | |
| 17 | 2018 | 9 | |
| 18 | 2017 | 22 | |
| 19 | 2015 | 19 | |
| 20 | 2015 | 3 |
About Qinan Yin
Qinan Yin is a scholar working on Cancer Research, Hematology and Aging, having authored 49 papers that have together received 596 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Erythrocyte Function and Pathophysiology (7 papers), Blood groups and transfusion (7 papers), MicroRNA in disease regulation (5 papers), Ferroptosis and cancer prognosis (5 papers), RNA modifications and cancer (5 papers) and Circular RNAs in diseases (5 papers). The work is most often cited by research in Cancer Research (138 citations), Oncology (216 citations) and Immunology (96 citations). Qinan Yin has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Lizhu Han, Rongsheng Tong, Lan Bai, Xingyue Zheng, Lian Li, Liuyun Wu, Yuan Bian, Willy A. Flegel, Xuewei Zheng and Inès Jedidi.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.